Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014, Article ID 427378, 8 pages
http://dx.doi.org/10.1155/2014/427378
Research Article

Low Paraoxonase 1 Activity Predicts Mortality in Surgical Patients with Sepsis

1Department of Anaesthesiology, Resuscitation and Intensive Care, Clinical Hospital Center Bezanijska Kosa, Bezanijska kosa bb, 11000 Belgrade, Serbia
2Faculty of Pharmacy, Vojvode Stepe 450, 11000 Belgrade, Serbia
3Clinical Center of Serbia, Pasterova 2, 11000 Belgrade, Serbia
4School of Medicine, University of Belgrade, Dr. Subotica 8, 11000 Belgrade, Serbia
5Clinical Chemistry Laboratory, Clinical Hospital Center Bezanijska Kosa, Bezanijska kosa bb, 11000 Belgrade, Serbia

Received 30 June 2013; Accepted 6 December 2013; Published 9 February 2014

Academic Editor: Kishore Chaudhry

Copyright © 2014 Suzana Bojic et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. S. Martins, E. G. Kallas, M. C. Neto, M. A. Dalboni, S. Blecher, and R. Salomão, “Upregulation of reactive oxygen species generation and phagocytosis, and increased apoptosis in human neutrophils during severe sepsis and septic shock,” Shock, vol. 20, no. 3, pp. 208–212, 2003. View at Google Scholar · View at Scopus
  2. H. F. Galley, “Oxidative stress and mitochondrial dysfunction in sepsis,” British Journal of Anaesthesia, vol. 107, no. 1, pp. 57–64, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. B. N. La Du, “Structural and functional diversity of paraoxonases,” Nature Medicine, vol. 2, no. 11, pp. 1186–1187, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Schrader and G. Rimbach, “Determinants of paraoxonase 1 status: genes, drugs and nutrition,” Current Medicinal Chemistry, vol. 18, no. 36, pp. 5624–5643, 2011. View at Google Scholar · View at Scopus
  5. L.-P. Précourt, D. Amre, M.-C. Denis et al., “The three-gene paraoxonase family: physiologic roles, actions and regulation,” Atherosclerosis, vol. 214, no. 1, pp. 20–36, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Keskin, E. Dolar, M. Dirican et al., “Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity,” Internal Medicine Journal, vol. 39, no. 4, pp. 243–248, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Duygu, S. Tekin Koruk, and N. Aksoy, “Serum paraoxonase and arylesterase activities in various forms of hepatitis B virus infection,” Journal of Clinical Laboratory Analysis, vol. 25, no. 5, pp. 311–316, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Franco-Pons, J. Marsillach, J. Joven, J. Camps, and D. Closa, “Serum paraoxonase undergoes inhibition and proteolysis during experimental acute pancreatitis,” Journal of Gastrointestinal Surgery, vol. 12, no. 5, pp. 891–899, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Y. Gbandjaba, N. Ghalim, M. Hassar et al., “Paraoxonase activity in healthy, diabetic, and hemodialysis patients,” Clinical Biochemistry, vol. 45, no. 6, pp. 470–474, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Kotur-Stevuljević, A. Peco-Antić, S. Spasić et al., “Hyperlipidemia, oxidative stress, and intima media thickness in children with chronic kidney disease,” Pediatric Nephrology, vol. 28, no. 2, pp. 295–303, 2013. View at Google Scholar
  11. S. Ribeiro, M. do Sameiro Faria, F. Mascarenhas-Melo et al., “Main determinants of PON1 activity in hemodialysis patients,” American Journal of Nephrology, vol. 36, no. 4, pp. 317–323, 2012. View at Google Scholar
  12. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference, “Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis,” Critical Care Medicine, vol. 20, no. 6, pp. 864–874, 1992. View at Google Scholar
  13. M. M. Berger, A. Marazzi, J. Freeman, and R. Chiolero, “Evaluation of the consistency of acute physiology and chronic health evaluation (APACHE II) scoring in a surgical intensive care unit,” Critical Care Medicine, vol. 20, no. 12, pp. 1681–1687, 1992. View at Google Scholar · View at Scopus
  14. R. Moreno, J.-L. Vincent, R. Matos et al., “The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study,” Intensive Care Medicine, vol. 25, no. 7, pp. 686–696, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. R. J. Richter and C. E. Furlong, “Determination of paraoxonase (PON1) status requires more than genotyping,” Pharmacogenetics, vol. 9, no. 6, pp. 745–753, 1999. View at Google Scholar · View at Scopus
  16. J. Kotur-Stevuljevic, L. Memon, A. Stefanovic et al., “Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients,” Clinical Biochemistry, vol. 40, no. 3-4, pp. 181–187, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. O. Erel, “A new automated colorimetric method for measuring total oxidant status,” Clinical Biochemistry, vol. 38, no. 12, pp. 1103–11111, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. O. Erel, “A novel automated method to measure total antioxidant response against potent free radical reactions,” Clinical Biochemistry, vol. 37, no. 2, pp. 112–119, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. D. H. Alamdari, M. Ghayour-Mobarhan, S. Tavallaie et al., “Prooxidant-antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease,” Clinical Biochemistry, vol. 41, no. 6, pp. 375–380, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Novak, L. Vavrova, J. Kodydkova, M. Hynkova, A. Zak, and O. Novakova, “Decreased paraoxonase activity in critically ill patients with sepsis,” Clinical and Experimental Medicine, vol. 10, no. 1, pp. 21–25, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Sans, A. Rull, J. Luna et al., “Monocyte chemoattractant protein-1 and paraoxonase-1 and 3 levels in patients with sepsis treated in an intensive care unit: a preliminary report,” Clinical Chemistry and Laboratory Medicine, vol. 50, no. 8, pp. 1409–1415, 2012. View at Google Scholar
  22. D. Draganov, J. Teiber, C. Watson et al., “PON1 and oxidative stress in human sepsis and an animal model of sepsis,” Advances in Experimental Medicine and Biology, vol. 660, pp. 89–97, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. C.-C. Chuang, S.-C. Shiesh, C.-H. Chi et al., “Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis,” Critical Care, vol. 10, no. 1, article R36, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Giovannini, C. Chiarla, F. Giuliante et al., “Serum uric acid, creatinine, and the assessment of antioxidant capacity in critical illness,” Critical Care, vol. 10, no. 5, article 421, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. A. F. McDonagh, “The biliverdin-bilirubin antioxidant cycle of cellular protection: missing a wheel?” Free Radical Biology & Medicine, vol. 49, no. 5, pp. 814–820, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Bobin-Dubigeon, I. Jaffre, M. P. Joalland et al., “Paraoxonase 1 (PON1) as a marker of short term death in breast cancer recurrence,” Clinical Biochemistry, vol. 45, no. 16-17, pp. 1503–1505, 2012. View at Google Scholar
  27. H. Wang, L. Li, L. Ding, Z. Zhang, and C. Pu, “Association of genetic polymorphisms in the paraoxonase 1 gene with the risk and prognosis of non-small cell lung cancer in Chinese Han population,” Journal of Investigative Medicine, vol. 60, no. 3, pp. 592–597, 2012. View at Google Scholar